Jinyun Dong
800 Dongchuan Road
Shanghai, 200240, China
Shanghai, 200240, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
MTSS1-dependent ubiquitin modifications mediated by FBXO44 remodel the actin cytoskeleton to promote gastric cancer progression.
Journal: Molecular cancer
Published: September 17, 2025
HSP70 Interactome-Mediated Proteolysis Targeting Chimera (HSP70-PROTAC) for Ferroptosis-Driven Cancer Treatment.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 19, 2025
A comprehensive proteomic analysis uncovers novel molecular subtypes of gastric signet ring cell carcinoma: Identification of potential prognostic biomarkers and therapeutic targets.
Journal: Genes & diseases
Published: December 13, 2024
An updated review on the role of small molecules in mediating protein degradation.
Journal: European journal of medicinal chemistry
Published: November 18, 2024
Heat Shock Protein 90 Interactome-Mediated Proteolysis Targeting Chimera (HIM-PROTAC) Degrading Glutathione Peroxidase 4 to Trigger Ferroptosis.
Journal: Journal of medicinal chemistry
Published: September 04, 2024
Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer.
Journal: Bioorganic & medicinal chemistry
Published: July 01, 2024
Small molecule inhibitors targeting heat shock protein 90: An updated review.
Journal: European journal of medicinal chemistry
Published: April 03, 2024
Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance.
Journal: Scientific reports
Published: January 11, 2024
ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation.
Journal: European journal of medicinal chemistry
Published: January 09, 2024
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance.
Journal: RSC medicinal chemistry
Published: November 03, 2023
Last Updated: 09/26/2026